Axcentua Pharmaceuticals AB

Axcentua is a privately held clinical stage pharmaceutical development company. It is pioneering a novel strategy, crystal re-engineering, for the accelerated transition of novel promising therapeutics from the preclinical to the clinical phase.

 

The core business idea is to decrease drug development time and cost as well as risk by creating novel crystalline forms of safe and well-characterized natural compounds with therapeutic potential. In so doing, the Company is developing new treatments for neglected diseases where treatments are either inadequate or completely lacking.

 

Kategorier: Pharma

Gå till Axcentua Pharmaceuticals ABs hemsida